About
Technology
Issues
FAQ
Search
filter by year
2024 (11)
2023 (120)
2022 (520)
2021 (537)
2020 (593)
2010-2019 (4,963)
2000-2009 (2,364)
1990-1999 (1,486)
1980-1989 (1,064)
1970-1979 (562)
1960-1969 (454)
1950-1959 (180)
1900-1950 (157)
Similar Keywords
houston (13,173)
texans (180)
1-20 of (13,349 documents found)
2017
3.6K
NF-κB signaling in inflammation
Signal Transduction and Targeted Therapy
(
7.1
★★★
), 2, .
Cite
Citations
Matthew Li (80, 6.9K)
2018
295
Urbanization exacerbated the rainfall and flooding caused by hurricane Harvey in Houston
Nature
(
13.7
★★★
), 563, 384-388.
Cite
Citations
Matthew Li (80, 6.9K)
2008
1.1K
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1
Nature Genetics
(
9.4
★★★
), 40, 616-622.
Cite
Citations
Matthew Li (80, 6.9K)
2015
812
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Clinical Cancer Research
(
3.2
★★★
), 21, 1688-1698.
Cite
Citations
Matthew Li (80, 6.9K)
2019
328
Marketing in the Sharing Economy
Journal of Marketing
(
7.0
★★★
), 83, 5-27.
Cite
Citations
Matthew Li (80, 6.9K)
2004
2.9K
PANEL COINTEGRATION: ASYMPTOTIC AND FINITE SAMPLE PROPERTIES OF POOLED TIME SERIES TESTS WITH AN APPLICATION TO THE PPP HYPOTHESIS
Econometric Theory
(
0.6
★★★
), 20, .
Cite
Citations
Matthew Li (80, 6.9K)
2016
714
Hepatocellular carcinoma: a review
Journal of Hepatocellular Carcinoma
(
1.8
★★★
), Volume 3, 41-53.
Cite
Citations
Matthew Li (80, 6.9K)
2014
360
Metallic nanostructures for light trapping in energy-harvesting devices
Light: Science and Applications
(
7.7
★★★
), 3, e161-e161.
Cite
Citations
Matthew Li (80, 6.9K)
2014
466
Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial
Lancet Oncology, The
(
5.1
★★★
), 15, 69-77.
Cite
Citations
Matthew Li (80, 6.9K)
2016
384
Markedly enhanced absorption and direct radiative forcing of black carbon under polluted urban environments
Proceedings of the National Academy of Sciences of the United States of America
(
3.3
★★★
), 113, 4266-4271.
Cite
Citations
Matthew Li (80, 6.9K)
2020
230
Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
Experimental and Molecular Medicine
(
3.2
★★★
), 52, 183-191.
Cite
Citations
Matthew Li (80, 6.9K)
2012
428
Circulating tumour cells in non-metastatic breast cancer: a prospective study
Lancet Oncology, The
(
5.1
★★★
), 13, 688-695.
Cite
Citations
Matthew Li (80, 6.9K)
2020
280
The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities
Cardiovascular Pathology
(
0.7
★★★
), 48, 107233.
Cite
Citations
Matthew Li (80, 6.9K)
2017
281
Use of Exome Sequencing for Infants in Intensive Care Units
JAMA Pediatrics
(
3.3
★★★
), 171, e173438.
Cite
Citations
Matthew Li (80, 6.9K)
2017
235
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study
Lancet Oncology, The
(
5.1
★★★
), 18, 100-111.
Cite
Citations
Matthew Li (80, 6.9K)
2016
300
Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma
Clinical Cancer Research
(
3.2
★★★
), 22, 3630-3642.
Cite
Citations
Matthew Li (80, 6.9K)
2012
369
Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study
Lancet Oncology, The
(
5.1
★★★
), 13, 403-411.
Cite
Citations
Matthew Li (80, 6.9K)
2008
679
Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension
JAMA - Journal of the American Medical Association
(
3.8
★★★
), 300, 924.
Cite
Citations
Matthew Li (80, 6.9K)
2018
188
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial
Lancet Oncology, The
(
5.1
★★★
), 19, 181-193.
Cite
Citations
Matthew Li (80, 6.9K)
2014
296
Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study
Lancet Oncology, The
(
5.1
★★★
), 15, 1090-1099.
Cite
Citations
Matthew Li (80, 6.9K)
1
2
3
site/software ©
exaly
; All materials licenced under
CC by-SA
.